Home › Funds › Prospect Capital Advisors, LLC › ETON
Prospect Capital Advisors, LLC position in ETON
ETON PHARMACEUTICALS INC COM · Health Care
Prospect Capital Advisors, LLC reported holding 157,200 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 2.58% of its reported portfolio and ranking #16 among its reported holdings. Prospect Capital Advisors, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Prospect Capital Advisors, LLC's ETON position evolved
Prospect Capital Advisors, LLC first disclosed a stake in ETON in Q2 2026 at 157,200 shares (US$5.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 157.20K | $5.69M | New |
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- EcoR1 Capital, LLC 2.17M sh · $78.62M · Q2 2026
- Nantahala Capital Management, LLC 1.18M sh · $42.57M · Q2 2026
- National Philanthropic Trust 492.11K sh · $17.81M · Q2 2026
- Westside Investment Management, Inc. 431.16K sh · $15.61M · Q2 2026
- Pillsbury Lake Capital LLC 387.16K sh · $14.02M · Q2 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Lumbard & Kellner, LLC 175.91K sh · $6.37M · Q2 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Aristides Capital LLC 145.41K sh · $5.26M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 137.57K sh · $4.98M · Q2 2026
More on Prospect Capital Advisors, LLC
FAQ
How long has Prospect Capital Advisors, LLC held ETON?
Prospect Capital Advisors, LLC has disclosed ETON holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Prospect Capital Advisors, LLC's current position in ETON?
As of Q2 2026, Prospect Capital Advisors, LLC holds 157.20K shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $5.69M, representing 2.58% of its reported portfolio and ranking #16.
Has Prospect Capital Advisors, LLC been buying or selling ETON?
In the latest 13F filing (Q2 2026), Prospect Capital Advisors, LLC newly opened its position in ETON.
Which other funds hold ETON?
Other major institutional holders of ETON include Opaleye Management Inc., EcoR1 Capital, LLC, Nantahala Capital Management, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.